Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Chatterjee, Cynthia ^a   Sparks, Daniel L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; INSULIN RECEPTOR; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PURINERGIC P2Y13 RECEPTOR; DIFFERENTIATION ANTIGEN; LIGHT CHAIN 3, HUMAN; MAPK1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; P2RY13 PROTEIN, HUMAN; PURINERGIC P2 RECEPTOR;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LIPOPROTEIN SECRETION; LIVER CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; BIOSYNTHESIS; CELL STRAIN HEPG2; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; PHAGOSOME; PHOSPHORYLATION; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANTIGENS, DIFFERENTIATION; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; AUTOPHAGY; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; LIVER; MAP KINASE SIGNALING SYSTEM; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHAGOSOMES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; RECEPTORS, PURINERGIC P2;

EID: 84861012301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036916     Document Type: Article

References (53)

1. Grundy SM, (1998) Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81: 18B-25B.
2. Adiels M, Olofsson SO, Taskinen MR, Boren J, (2008) Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 1225-1236.
3. Solini A, Iacobini C, Ricci C, Chiozzi P, Amadio L, et al. (2005) Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases. Kidney Int 67: 875-885.
4. Nilsson J, Nilsson LM, Chen YW, Molkentin JD, Erlinge D, et al. (2006) High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26: 794-800.
5. Di VF, Solini A, (2002) P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135: 831-842.
6. Di VF, Boeynaems JM, Robson SC, (2009) Extracellular nucleotides as negative modulators of immunity. Curr Opin Pharmacol 9: 507-513.
7. Brown PR, Parks RE Jr, Herod J, (1973) Use of high-pressure liquid chromatography for monitoring nucleotide concentration in human blood: a preliminary study with stored blood cell suspensions. Clin Chem 19: 919-922.
8. Harkness RA, Coade SB, Webster AD, (1984) ATP, ADP and AMP in plasma from peripheral venous blood. Clin Chim Acta 143: 91-98.
9. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, et al. (2007) CD39 and control of cellular immune responses. Purinergic Signal 3: 171-180.
10. Erlinge D, Burnstock G, (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4: 1-20.
11. Khakh BS, North RA, (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442: 527-532.
12. Trautmann A, (2009) Extracellular ATP in the immune system: more than just a "danger signal". Sci Signal 2: pe6.
13. Sellers MB, Tricoci P, Harrington RA, (2009) A new generation of antiplatelet agents. Curr Opin Cardiol 24: 307-312.
14. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, et al. (2003) Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 421: 75-79.
15. Jacquet S, Malaval C, Martinez LO, Sak K, Rolland C, et al. (2005) The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci 62: 2508-2515.
16. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, et al. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9: 352-355.
17. Li X, Millar JS, Brownell N, Briand F, Rader DJ, (2010) Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes. Biochem Pharmacol 80: 1450-1457.
18. Zhang LH, Kamanna VS, Zhang MC, Kashyap ML, (2008) Niacin inhibits surface expression of ATP synthase {beta} chain in HepG2 cells: implications for raising HDL. J Lipid Res 49: 1195-1201.
19. Pandey NR, Renwick J, Rabaa S, Misquith A, Kouri L, et al. (2009) An induction in hepatic HDL secretion associated with reduced ATPase expression. Am J Pathol 175: 1777-1787.
20. Pandey NR, Renwick J, Misquith A, Sokoll K, Sparks DL, (2008) Linoleic Acid-Enriched Phospholipids Act through Peroxisome Proliferator-Activated Receptors alpha To Stimulate Hepatic Apolipoprotein A-I Secretion. Biochemistry 47: 1579-1587.
21. Hopewell S, Pandey NR, Misquith A, Twomey E, Sparks DL, (2008) Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion. Metabolism 57: 1677-1684.
22. Fisher EA, Zhou MY, Mitchell DM, Wu XJ, Omura S, et al. (1997) The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J Biol Chem 272: 20427-20434.
23. Adeli K, Macri J, Mohammadi A, Kito M, Urade R, et al. (1997) Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells. J Biol Chem 272: 22489-22494.
24. Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, et al. (2007) Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171: 513-524.
25. Zhu K, Dunner K Jr, McConkey DJ, (2010) Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29: 451-462.
26. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, et al. (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435.
27. Kroemer G, Marino G, Levine B, (2010) Autophagy and the integrated stress response. Mol Cell 40: 280-293.
28. De Meyer GR, Martinet W, (2009) Autophagy in the cardiovascular system. Biochim Biophys Acta 1793: 1485-1495.
29. Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA, (2011) Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 51: 584-593.
30. Yang Z, Klionsky DJ, (2010) Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822.
31. Fabre AC, Vantourout P, Champagne E, Terce F, Rolland C, et al. (2006) Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci 63: 2829-2837.
32. Rutledge AC, Qiu W, Zhang R, Kohen-Avramoglu R, Nemat-Gorgani N, et al. (2009) Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus. Arterioscler Thromb Vasc Biol 29: 579-585.
33. Behan MW, Chew DP, Aylward PE, (2010) The role of antiplatelet therapy in the secondary prevention of coronary artery disease. Curr Opin Cardiol 25: 321-328.
34. Cattaneo M, (2010) New P2Y(12) inhibitors. Circulation 121: 171-179.
35. Lukasova M, Malaval C, Gille A, Kero J, Offermanns S, (2011) Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 121: 1163-1173.
36. Chatterjee C, Young EK, Pussegoda KA, Twomey EE, Pandey NR, et al. (2009) Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase. Biochemistry 48: 5994-6001.
37. Lewis GF, Rader DJ, (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96: 1221-1232.
38. Meshkani R, Adeli K, (2009) Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 42: 1331-1346.
39. Ranganathan S, Kottke BA, (1990) Rapid regulation of apolipoprotein A-I secretion in HepG2 cells by a factor associated with bovine high-density lipoproteins. Biochim Biophys Acta Lipids Lipid Metab 1046: 223-228.
40. Schofl C, Ponczek M, Mader T, Waring M, Benecke H, et al. (1999) Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am J Physiol 276: G164-G172.
41. Malaval C, Laffargue M, Barbaras R, Rolland C, Peres C, et al. (2009) RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes. Cell Signal 21: 120-127.
42. Heeren J, Grewal T, Laatsch A, Rottke D, Rinninger F, et al. (2003) Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J Biol Chem 278: 14370-14378.
43. Rohrer L, Cavelier C, Fuchs S, Schluter MA, Volker W, et al. (2006) Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. Biochim Biophys Acta 1761: 186-194.
44. Denis M, Landry YD, Zha X, (2008) ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments. J Biol Chem 283: 16178-16186.
45. Fabre AC, Malaval C, Ben AA, Verdier C, Pons V, et al. (2010) P2Y13 receptor is critical for reverse cholesterol transport. Hepatology 52: 1477-1483.
46. Blom D, Yamin TT, Champy MF, Selloum M, Bedu E, et al. (2010) Altered lipoprotein metabolism in P2Y(13) knockout mice. Biochim Biophys Acta 1801 1349-1360 pp. 1349-1360.
47. Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, et al. (1996) Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 97: 2408-2416.
48. Dixon CJ, Hall JF, Boarder MR, (2003) ADP stimulation of inositol phosphates in hepatocytes: role of conversion to ATP and stimulation of P2Y2 receptors. Br J Pharmacol 138: 272-278.
49. Communi D, Gonzalez NS, Detheux M, Brezillon S, Lannoy V, et al. (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276: 41479-41485.
50. Marteau F, Le PE, Communi D, Communi D, Labouret C, et al. (2003) Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64: 104-112.
51. Tan C, Salehi A, Svensson S, Olde B, Erlinge D, (2010) ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells. Cell Mol Life Sci 67: 445-453.
52. Pandey NR, Sultan K, Twomey E, Sparks DL, (2009) Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells. Neuroscience 164: 1744-1753.
53. Amisten S, Meidute-Abaraviciene S, Tan C, Olde B, Lundquist I, et al. (2010) ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 53: 1927-1934.